LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) Insider Trading & SEC Filings

Updated Jul 16, 2026 · Last SEC filing 2026-06-08

LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) has filed 9 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-06-08. 3 Form 8-K material event filings were reported by LFCR in the last 90 days. InsiderAlpha tracks every LFCR SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About LIFECORE BIOMEDICAL, INC. \DE\ (LFCR)

SIC classification	Pharmaceutical Preparations (SIC 2834)
SEC CIK	0001005286

90-Day SEC Filing Activity

Form 4 filings (90d)	9
Form 8-K filings (90d)	3
Latest Form 4 filing	2026-06-08

Recent LFCR Insider Transactions (Form 4)

Date	Insider	Role	Transaction	Shares	Price	Value	Filing
2026-06-04	Antunes Humberto Calheiros	Director	A — Grant or award	25.9K	—	—	SEC
2026-06-04	Korenberg Matthew E	Director	A — Grant or award	25.9K	—	—	SEC
2026-06-04	Kiper Christopher S	Director	A — Grant or award	25.9K	—	—	SEC
2026-06-04	Johnson Paul Harold	Director	A — Grant or award	25.9K	—	—	SEC
2026-06-04	Aryeh Jason	Director	A — Grant or award	25.9K	—	—	SEC
2026-06-04	OBUS NELSON	Director	A — Grant or award	25.9K	—	—	SEC
2026-06-04	Schechter Joshua	Director	A — Grant or award	25.9K	—	—	SEC
2026-06-04	HOUDE LOVAS KATRINA	Director	A — Grant or award	25.9K	—	—	SEC
2026-05-20	Josephs Paul	Chief Executive Officer	F — Tax withholding / forfeiture	40.4K	$4.57	$185K	SEC
2026-04-14	Salus Thomas D.	Chief Legal & Administration	F — Tax withholding / forfeiture	24.6K	$5.20	$128K	SEC
2026-03-02	Salus Thomas D.	Chief Legal & Administration	A — Grant or award	30.0K	—	—	SEC
2025-09-03	Lake Ryan David	Chief Financial Officer	F — Tax withholding / forfeiture	22.9K	$7.71	$177K	SEC
2025-07-15	Schechter Joshua	Director	A — Grant or award	19.5K	—	—	SEC
2025-07-15	OBUS NELSON	Director	A — Grant or award	19.5K	—	—	SEC
2025-07-15	Aryeh Jason	Director	A — Grant or award	19.5K	—	—	SEC

All transactions sourced from SEC EDGAR Form 4 filings for LIFECORE BIOMEDICAL, INC. \DE\ (LFCR). Updated in real time as new filings are submitted to the SEC.

Most-Active LFCR Insiders — Last 90 Days

Insider	Form 4 filings	Total transaction value
Josephs Paul	1	$185K
Kiper Christopher S	1	—
HOUDE LOVAS KATRINA	1	—
Schechter Joshua	1	—
Antunes Humberto Calheiros	1	—

Recent LFCR Form 8-K Material Events

2026-07-02 — Item 7.01 [SEC]
2026-06-05 — Item 5.02, 5.07, 9.01 [SEC]
2026-05-06 — Item 2.02, 7.01, 9.01 [SEC]
2026-03-16 — Item 2.02, 7.01, 9.01 · Earnings · neutral [SEC]
Lifecore Biomedical announced consolidated financial results for the fourth quarter and transition period ended December 31, 2025, along with investor presentation materials. The filing provides standard financial reporting without explicit beat/miss language or forward guidance
2026-03-05 — Item 5.08 · Other · neutral [SEC]
Lifecore Biomedical announced a change in its fiscal year from a May-end fiscal year to a calendar year (December 31) effective for the period beginning May 26, 2025. The company has scheduled its 2026 Annual Meeting of Stockholders for June 4, 2026, and established a March 16, 2

Recent Insider Filings

2026-06-08 — Kiper Christopher S (Director)
2026-06-05 — OBUS NELSON (Director)
2026-06-05 — Aryeh Jason (Director)
2026-06-05 — Schechter Joshua (Director)
2026-06-05 — Korenberg Matthew E (Director)

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in LFCR insider filings:

P	Open-market purchase by the insider
S	Open-market sale by the insider
A	Grant, award, or other acquisition from the issuer
M	Exercise or conversion of derivative security (e.g. options)
F	Payment of exercise price or tax liability via share withholding
G	Bona-fide gift of securities
D	Disposition to the issuer (e.g. share buyback participation)
J	Other acquisition or disposition
X	Exercise of in-the-money or at-the-money derivative security
C	Conversion of derivative security
V	Transaction voluntarily reported earlier than required

LFCR Insider Trading — FAQ

What is the latest insider trade for LFCR?: LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) had 9 insider filings in the last 90 days, with the most recent on 2026-06-08. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying LFCR stock?: 0 insider purchases of LFCR were filed in the last 90 days.
How many insiders are selling LFCR stock?: 0 insider sales of LFCR were filed in the last 90 days.
Where can I see LFCR SEC filings (Form 4, 10-K, 10-Q, 8-K)?: InsiderAlpha aggregates every LFCR SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Related Companies — Recent Insider Activity

Learn More

Open the live LFCR dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.